Evidence mapPaperPMID 29862285Full record

SynthesisBioMed research international2018

Fertility Drugs Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis.

QingAn Yu, XiaoYing Lv, KunPeng Liu, DaKun Ma, YaoHua Wu, WenJie Dai, HongChi Jiang

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

QingAn YuDepartment of Thyroid Surgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
XiaoYing LvDepartment of Ophthalmic Clinic, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
KunPeng LiuDepartment of Thyroid Surgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
DaKun MaDepartment of Thyroid Surgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
YaoHua WuDepartment of Thyroid Surgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
WenJie DaiDepartment of Thyroid Surgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.ORCID 0000-0001-6334-946X
HongChi JiangDepartment of Liver Surgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.ORCID 0000-0001-8215-8984
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Associations have been demonstrated between fertility drugs and a variety of hormone-sensitive carcinomas. The purpose of this study was to determine the relationship between fertility drugs used in the treatment of female infertility and the risk of thyroid cancer. To investigate the clinical significance of fertility drugs used for the treatment of female infertility and the risk associated with thyroid cancer, we performed a literature search using PubMed, MEDLINE, the Cochrane Library, the Web of Science, and EBSCOHOST for comparative studies published any time prior to July 21, 2017. The studies included women who were treated for infertility with fertility drugs, such as clomiphene citrate, gonadotropins, or other unspecified fertility agents, which reported the incidence of thyroid cancer as the main outcome. Eight studies were included in the meta-analyses. Among women with infertility, there was a significant positive association between thyroid cancer risk and the use of fertility drugs (relative risk [RR] = 1.35; 95% confidence interval [CI] 1.12-1.64;

Indexed as

Infertility, FemaleThyroid NeoplasmsClomipheneFemaleFertility AgentsGonadotropinsHumansRisk FactorsClomipheneFertility AgentsGonadotropins

Identifiers

PMID29862285
PMCPMC5971354
OpenAlexW2802631746

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.